Tao Synergies (TAOX) Stock Price & Analysis
TAOX Stock Chart & Stats
$2.77-$0.06(-2.12%)
At close: 11:10 AM EST
- Day’s Range
- $2.82 - $3.19
- 52-Week Range
- $2.82 - $9.00
- Previous Close
- $3.16
- Volume
- N/A
- Average Volume (3M)
- 196.98K
- Market Cap
- $22.77M
- Enterprise Value
- $8.97T
- Total Cash (Recent Filing)
- $19.18M
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- ―
- Beta
- 1.81
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Tao Synergies News
TAOX FAQ
What was Tao Synergies’s price range in the past 12 months?
Tao Synergies lowest stock price was $2.82 and its highest was $9.00 in the past 12 months.
What is Tao Synergies’s market cap?
Tao Synergies’s market cap is $22.77M.
When is Tao Synergies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Tao Synergies overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Tao Synergies pay dividends?
Tao Synergies does not currently pay dividends.
What is Tao Synergies’s EPS estimate?
Tao Synergies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tao Synergies have?
Tao Synergies has 8,044,885 shares outstanding.
Which hedge fund is a major shareholder of Tao Synergies?
Hedge funds hold Tao Synergies shares: the largest hedge-fund position in Tao Synergies is 71,886,744 shares, and hedge funds increased their holdings by 26.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tao Synergies
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
- Sector
- Technology
- Industry
- Software - Application
- CEO
- Joshua N. Silverman
- Employees
- 5
- Website
- www.taosynergies.com
- Address
- 1185 Avenue of the Americas, 3rd Floor, New York, NY, 10036, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |
